Great Point Partners LLC Aurinia Pharmaceuticals Inc. Transaction History

Great Point Partners LLC

  • $216 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 17, 2021
SELL
$12.3 - $18.73 $2.15 Million - $3.28 Million
-175,000 Closed
0 $0
Q4 2020

Feb 16, 2021
SELL
$12.94 - $16.05 $29.9 Million - $37.1 Million
-2,310,327 Reduced 92.96%
175,000 $2.42 Million
Q3 2020

Nov 16, 2020
BUY
$13.19 - $16.66 $32.8 Million - $41.4 Million
2,485,327 New
2,485,327 $36.6 Million

Others Institutions Holding AUPH

# of Institutions
207
Shares Held
58.6M
Call Options Held
1.14M
Put Options Held
1.51M
View Full List

About Aurinia Pharmaceuticals Inc.

AUPH Quotes by TradingView
  • Ticker AUPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,892,000
  • Market Cap $1.28B
  • Description
  • Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...
More about AUPH
Track This Portfolio

Track Great Point Partners LLC Portfolio

Follow Great Point Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Great Point Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Great Point Partners LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email